CBD has become a huge industry in Canada, and it’s well on its way in the United States. One country that will be a huge market for CBD is China. With all of its uses, and China being one of the world’s largest consumer markets CBD in China is going to be a boon.
This is why we’re very excited to introduce you to ChineseInvestors.com, Inc. (CIIX). CIIX is a premier Chinese company that has jumped directly into the CBD industry with its wholly owned subsidiary CBD Biotechnology Co. who just launched a two-tier direct selling initiative to accelerate their CBD sales in China. CIIX is also attending
Some CBD stocks to consider include: ChineseInvestors.com, Inc. (CIIX), Canopy Growth Corporation (CGC), Aurora Cannabis (ACBFF), CV Sciences, Inc. (CVSI), and GW Pharmaceuticals (GWPH).
ChineseInvestors.com, Inc. (CIIX)
Market Cap: $16.85M Share Price: $0.515
ChineseInvestors.com, Inc. (CIIX), the premier financial information website for Chinese-speaking investors, announced that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., has launched a two-tier, direct selling initiative to accelerate its CBD sales into China. In addition, the Company has appointed marketing expert Mr. Fengxian Xie as President of its CBD Community Center, effective immediately. The goal of the CBD Community Center initiative is to establish a new, effective marketing channel to further stimulate demand for CBD Biotech’s innovative CBD-infused skin care products.
Canopy Growth Corporation (CGC)
Market Cap: $11.54B Share Price: $52.00
Constellation Brands announced a partnership with Canopy Growth back in October. Investors benefited recently from the partnership as Constellation Brands pledged an additional $4 billion to their stake in the company. Recently, through its wholly-owned subsidiary Tweed Inc., has been selected as an approved supplier by the Ontario Cannabis Store to supply a wide variety of cannabis products through its online store starting October 17th, 2018.
Aurora Cannabis (ACBFF)
Market Cap: $6.36B Share Price: $6.615
Aurora Cannabis is receiving investor attention after announcing that its acquisition of Anandia Laboratories Inc. is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act (British Columbia), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction.
CV Sciences, Inc. (CVSI)
Market Cap: $379.87M Share Price: $4.19
CV Sciences (CVSI) has received more positive attention after it announced that it had appointed Joseph Maroon, MD, FACS to its Board of Directors. The Nevada-based company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
GW Pharmaceuticals, Inc. (GWPH)
Market Cap: $4.08B Share Price: $144.82
Stifel analyst Paul Matteis initiated coverage of GW Pharma with a Buy rating and $181 price target. Matteis expects a strong launch for Epidiolex. GW Pharma said Epidiolex would cost about $32,500 per year.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and nine dollars total by Regal Consulting. LLC, for news commentary articles for CIIX. CIIX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. We may buy or sell additional shares of CIIX in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States